Celldex Therapeutics | CLDX - Ebitda

Cena Akcji
33.29
Dzienna Zmiana
-0.26 -0.78%
Miesięcznie
5.08%
Rocznie
70.11%
Q2 Prognozy TE
33.79




Ebitda Zmiana Data
AbbVie USD 3.52B 828M 2025-09
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 5.14B 775M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Celldex Therapeutics USD -86.34M 13.54M 2025-12
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Northwest Biotherapeutics USD -13.41M 232K 2023-09
Pfizer USD 6.08B 351M 2025-09
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Roche Holding CHF 12.68B 2.36B 2024-06